References
- Douglas SJ. (1990). Process for the preparation of a ranitidine resin absorbate. Glaxo Group Research Ltd., EP 0 431 759.
- Astruc J, Sambot A. (1970). Ion-exchange resin: Spiramycin compositions. US patent, GB 1,180,233.
- Borodkin S, Sundberg DP. (1971). Chewable tablets including coated particles of psuedo-ephedine-weak cation exchange resin. US patent, US 3,594,470.
- Chapman DG, Shenoy KG, Campbell JA. (1959). Sustained release of drugs in certain drug-resin complexes as judged by urinary excretion rates. Can Med Assoc J, 81:470–7.
- Eichman ML. (1991). Sustained release drug-resin complexes. US patent 4996047.
- Lycored. (2007). Vitamin B12 tablets on resin 1%. http://www.lycored.com/Retriever/web/ui/ProductDocument.aspx? DID=1&PID=733/ [accessed 14 May 2008].
- Gao R, Shao ZJ, Fan ACL, Witchey-Lakshmanan LC, Stewart DC. (2003). Taste masking of oral Quinolone liquid preparations using ion exchange resins. US patent 6,514,492.
- Nie S, Fan X, Peng Y, Yang X, Wang C, Pan W. (2007). In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin. Arch Pharm Res, 30:991–1001.
- Hassan M, Sulieman M, Najib N. (1990). Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β‐cyclodextrin. Int J Pharm, 58:19–24.
- Whiffen DH. (1968). Raman spectra. In: Whiffen DH, ed. Spectroscopy. 2nd ed. New York: John Wiley and Sons, Inc., 109–14.
- Tawakkul MA, Shah RB, Sayeed VA, Khan MA. (2009). Complexation of risperidone with a taste masking resin: Application of near infra-red and chemical imaging to evaluate complexes. Pharm Dev Tech (in press).
- Halder A, Maiti S, Sa B. (2005). Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex. Int J Pharm, 302:84–94.